Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
ClinGen's cancer somatic working group hopes the adoption of its Minimal Variant Level Data (MVLD) framework will facilitate data exchange between institutions and help with variant interpretation.
The recent decision by a top UK research institute to outsource its data storage to a lower-cost, clean energy facility in Iceland has observers taking notice.
The company's Connect platform provides a forum for data holders to share their high-value datasets and receive royalties from the use of their data.
The company launched an updated version of its Face2Gene software suite earlier this month at the American Society of Human Genetics annual meeting.
The metrics are intended to provide an objective and constant way of evaluating the value of the repositories as well as the datasets they contain.
Multiple variant databases are creating competition among groups that disagree on how to advance the most scientifically robust and sustainable sharing model.
The partners will provide testing through a program through which they also plan to establish a database of genetic test results and patient outcomes.
Researchers are using GenomeDx's database to improve understanding of the genomic underpinnings of prostate cancer and advance personalized treatment strategies.
The team has received around $900,000 in National Cancer Institute funding to develop new capabilities for CIVIC, improve curation, and engage with the community.
In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.
Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.
The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.
Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.